IL-33 and ST2 levels in both the serum and synovium of patients with rheumatoid arthritis, systemic sclerosis, and systemic lupus erythematosus are significantly increased, and levels are correlated with disease severity [3,169,170,171]. Here, IL33 is linked to systemic lupus erythematosus.